(c) 2024 PillSync.com

Canada Dextroamphetamine 5 mg

INDICATIONS & USAGE: treatment of Attention Deficit Hyperactivity Disorder...MISUSE OF AMPHETAMINE MAY CAUSE SUDDEN DEATH AND SERIOUS CARDIOVASCULAR ADVERSE EVENTS....AMPHETAMINES HAVE A HIGH POTENTIAL FOR ABUSE....Specific etiology of this syndrome is unknown, and there is no single diagnostic test...The mode of therapeutic action in Attention Deficit Hyperactivity Disorder (ADHD) is not known...Amphetamines are non-catecholamine sympathomimetic amines with CNS stimulant activity...AMPHETAMINES HAVE A HIGH POTENTIAL FOR ABUSE...Amphetamines have a high potential for abuse;prolonged administration may lead to dependence...mode of therapeutic action in Attention Deficit Hyperactivity Disorder (ADHD) is not known...treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy...Adults: Efficacy was established in one 4-week controlled trial in adults...Adolescents (ages 13-17):...Children (ages 6-12)...treatment of attention deficit hyperactivity disorder (ADHD)...CNS stimulants...high potential for abuse and dependence...ADHD...attention deficit hyperactivity disorder...


4 years ago   round orange D 5 APO score Canada Dextroamphetamine 5 mg

round orange D 5 APO score

4 years ago   round orange D 5 APO score Canada Dextroamphetamine 5 mg

round orange D 5 APO score

Comments

Related Pills

dextroamphetamine sulfate tablet

teva pharmaceuticals usa, inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site